Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News SPDR Series Trust - SPDR S&P Biotech ETF XBI

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (ARCA:XBI)

Let volatility power your micro-cap biotechs

The Life Sciences Report April 28, 2016

Breaking Down Biotech ETFs With Leverage

Benzinga.com  October 2, 2015

ETF Outlook: More Biotech Blunders Or A Biotech Bounce?

Benzinga.com  September 27, 2015

Traders Bet Against Hillary With Leveraged Biotech ETF

Benzinga.com  September 23, 2015

Investors In This Biotech ETF Must Have Loved Hillary Clinton's Tweet

Benzinga.com  September 22, 2015

A Bad Sign For Biotech Bulls

Benzinga.com  August 20, 2015

Bullboard Posts (ARCA:XBI)

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
GwenTracy - April 13, 2023

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

   
GwenTracy - July 15, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >>
GwenTracy - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

 
GwenTracy - June 2, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

GwenTracy - May 11, 2022

FSD Pharma Inc: Lucid MS Video

<< View Post To Watch Video >>
GwenTracy - April 30, 2022